This document provides information to select heart failure patients who would benefit most from the CardioMEMS HF System, along with BNP thresholds.
Note: The CHAMPION trial specifically excluded patients with American College of Cardiology/ American Heart Association stage D heart failure who needed advanced therapies (i.e., left ventricular assist device, transplant or inotropic support). Even if inotropic support improved heart failure symptoms, a patient would still be defined as stage D, with refractory heart failure.²
CardioMEMS HF System Patient Approach with Philip B. Adamson, MD, MSC, FACC (06:01)
In this video, Philip B. Adamson, M.D., MSc, FACC, reviews essential tips for approaching patients about their symptoms and engaging in conversation about the CardioMEMS HF System.
CardioMEMS HF System Patient Approach with Jamie Pelzel, MD (07:43)
In this video, Jamie Pelzel, MD, reviews essential tips to approaching patients about their symptoms and engaging in conversation about the CardioMEMS HF System.
CardioMEMS HF System Patient Approach with Stephanie Preister, CNP (05:46)
In this video, Stephanie Preister, CNP, leads a discussion with patients about the CardioMEMS HF System and patient compliance.
MAT-2006770 v6.0